Shares of BeyondSpring Inc. (NASDAQ:BYSI - Get Free Report) traded down 13.8% during mid-day trading on Monday . The stock traded as low as $1.87 and last traded at $1.88. 44,776 shares traded hands during trading, an increase of 40% from the average session volume of 31,918 shares. The stock had previously closed at $2.18.
BeyondSpring Stock Performance
The company has a fifty day moving average of $2.20 and a two-hundred day moving average of $1.82.
BeyondSpring (NASDAQ:BYSI - Get Free Report) last posted its earnings results on Monday, May 12th. The company reported ($0.06) earnings per share for the quarter.
BeyondSpring Company Profile
(
Get Free Report)
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Further Reading
Before you consider BeyondSpring, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BeyondSpring wasn't on the list.
While BeyondSpring currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
